ArticleBMJ public health2023
Characteristics associated with high hospital spending over 1 year among patients hospitalised for COVID-19 in the USA: a cohort study.
Article in BMJ public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Introduction: Despite complex care needs during critical COVID-19, the associated long-term healthcare spending is poorly understood, limiting the ability of policy-makers to prioritise necessary care and plan for future medical countermeasures. Methods: We conducted a retrospective cohort study of adults hospitalised with COVID-19 in the USA (April‒June 2020) using data from the national PINC AI Healthcare Database. Patients were followed for 365 days to measure hospital spending starting on the date of admission. We used a multivariable logistic model to identify characteristics associated with high spending. Results: Among 73 606 patients hospitalised with COVID-19, 73% were aged ≥50 years, 51% were female, and 37% were non-Hispanic white. Mean hospital spending per patient over 90 days was US$28 712 (SD=US$48 583) and over 365 days was US$31 768 (SD=US$52 811). Patients who received care in the intensive care unit (36% vs 23% no intensive care, p<0.001), received a non-recommended COVID-19 treatment (28% vs 25% no treatment, p<0.001), had a longer length of stay (p<0.001), and had Medicare (27% vs 22% commercial, p<0.001) or Medicaid (25% vs 22% commercial, p<0.001) insurance were associated with a higher predicted probability of high hospital spending over 365 days. Patients who received recommended treatment (21% vs 25% no treatment, p<0.001) and were Hispanic and any race (24% vs 26% non-Hispanic white, p<0.001), non-Hispanic Asian (25% vs 26% non-Hispanic white, p=0.011), 'other' or unknown race and ethnicity (24% vs 26% non-Hispanic white, p<0.001), or female (25% vs 26% male, p<0.001) were associated with a lower predicted probability of high hospital spending. Conclusions: Most hospital spending incurred over 1 year was for care within 90 days of admission. Patients receiving complex care or non-recommended treatments were associated with higher spending, while those receiving recommended treatments were associated with lower spending. These findings can inform pandemic preparedness planning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.